Allergy Therapeutics PLC on Wednesday said that phase-3 trials of its grass allergy injection yielded positive results, moving the product closer to market entry.
The Sussex-based biotechnology.
The following stocks are the leading risers and fallers on AIM in London on Wednesday.
AIM - WINNERS
Impellam Group PLC, up 26% at 819.12 pence, 12-month range 580.00p-950.00p..
Allergy Immunotherapy Market Size, Share, Price, Trends, openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
Allergy Therapeutics PLC - Worthing, England-based commercial biotechnology company - Says it has successfully extended its cash runway to the end of January. Continues to work on cost control.
Peanut Allergy Pipeline Analysis (2023) Covering Clinical openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.